May vaptans contribute to the treatment of refractory ascites?

J Hepatol. 2010 Aug;53(2):225-7. doi: 10.1016/j.jhep.2010.04.003. Epub 2010 Apr 29.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antidiuretic Hormone Receptor Antagonists*
  • Ascites / therapy*
  • Combined Modality Therapy
  • Diuretics / therapeutic use
  • Dose-Response Relationship, Drug
  • Humans
  • Hyponatremia / drug therapy
  • Liver Cirrhosis / complications*
  • Morpholines / therapeutic use*
  • Paracentesis
  • Spiro Compounds / therapeutic use*
  • Spironolactone / therapeutic use
  • Treatment Outcome

Substances

  • Antidiuretic Hormone Receptor Antagonists
  • Diuretics
  • Morpholines
  • Spiro Compounds
  • Spironolactone
  • satavaptan